This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Regenerative Medicine Industry

NEW YORK, March 20, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Regenerative Medicine Industry,_Tissue_Banking_and_Transplantation

This report analyzes the worldwide markets for Regenerative Medicine in US$ million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., Evotec AG, Forticell Bioscience, Inc., Geron Corporation, Integra LifeSciences Corporation, LifeCell Corporation, Osiris Therapeutics, Inc., Tengion, Inc., Tepha Inc., and TiGenix N.V. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3II. EXECUTIVE SUMMARY


A Primer II-1

Current and Future Analysis II-1

Current Global Market for Regenerative Medicine II-2

Therapeutic Companies and Products in Regenerative Medicine -

Current Status II-2

Select Therapeutic Regenerative Medicine Products in the

Global Market II-3

Market Potential II-3

2. REGENERATIVE MEDICINE IN BONE AND JOINT APPLICATIONS II-5An Overview of Regenerative Medicine in Bone and JointApplications II-5Bone Graft Substitutes - Penetration in Foot and Ankle Surgeries II-5Repair of Non-Healing Bones - High Market Potential II-5Market Potential of Bone Graft Substitutes (BGSs) II-6Table 1: Global Bone Graft Substitute Market (2010):Percentage Share Breakdown of Sales for DePuy, OrthoVita,ApaTech/ Baxter, Wright Medical, Medtronic/RTI, Biomet, andOthers (includes corresponding Graph/Chart) II-6Synthetic Bone Graft Substitutes to Replace TraditionalAutografts and Allografts II-6Select Synthetic Products in Orthobiologics II-7Bone Morphogenic Proteins (BMPs) Gaining Popularity II-7Bone Morphogenic Protein products in Orthobiology II-7Table 2: Global Bone Morphogenic Protein Market (2010):Percentage Share Breakdown of Sales for Medtronic/RTI, andStryker (includes corresponding Graph/Chart) II-7Demineralized Bone Matrices (DBMs) Market Getting Crowded II-8Table 3: Global Demineralized Bone Matrix Market (2011):Percentage Share Breakdown of Value Sales for Medtronic/RTI,Synthes/MTF, Integra LifeSciences, Altiva, Bacterin, andOthers (includes corresponding Graph/Chart) II-8Select DBM products in Orthobiologics market II-8Biomaterials Market - Promising Opportunities for Cost-Effective Products II-8Existing Bone Graft Procedures - Limitations and Concerns II-9Autograft Procedures II-9Allograft - DBM and Other Allografts II-9BMPs and Other Synthetic Growth Factors II-9Medical Devices and Implants for Orthopedics II-10Expanding Opportunities in Hip and Knee Market II-10Extremity Reconstruction - A Growing Market II-10Tissue Engineered Cartilage Market - An Overview II-11Tissue Engineered Cartilages - A Promising Solution forCartilage Repair II-11Market Potential of Tissue Engineered Cartilage Products II-11Potential Applications of Tissue Engineered Cartilage Products II-11Commercially Available tissue engineered cartilage products II-12Challenges in Clinical Application of Tissue EngineeredCartilage Products II-13Bone Marrow Transplants (BMTs) II-13Market Potential for BMTs II-14Companies Engaged in CBSC Research for BMTs II-14Table 4: Global Orthobiologics Market (2010): PercentageShare Breakdown of Value Sales for Medtronic/RTI,Synthes/MTF, DePuy, Osteotech, Orthofix, and Others(includes corresponding Graph/Chart) II-14

Table 5: Global Orthobiologics Market (2010): Percentage

1 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%
YHOO $27.97 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs